Dailymed zolmitriptan orally disintegrating tablets mechanism of action?

How does zolmitriptan orally disintegrating tablets work?

Zolmitriptan is a serotonin (5-HT) receptor agonist used to treat migraine. Its mechanism centers on acting at serotonin receptors—especially 5-HT1B and 5-HT1D in the trigeminal vascular system—to help stop migraine attacks by counteracting the signaling that drives headache. [1]

Which serotonin receptors does it target?

Zolmitriptan’s antimigraine effect comes from agonism at 5-HT1B and 5-HT1D receptors, which are involved in regulating cranial blood vessels and trigeminal nerve activity. By stimulating these receptors, the drug helps reduce migraine-related pathways that contribute to pain and associated symptoms. [1]

What is happening in the trigeminal system when zolmitriptan is taken?

Migraine involves activation of trigeminal pathways and release of neuropeptides that contribute to head pain and inflammation. By activating 5-HT1B/1D receptors, zolmitriptan reduces this trigeminal signaling and helps limit the processes that lead to migraine symptoms. [1]

Does the orally disintegrating tablet change the mechanism?

The mechanism of action is the same for zolmitriptan regardless of formulation. The orally disintegrating tablet is designed to dissolve on the tongue for ease of administration, but it is still zolmitriptan acting as a 5-HT1B/1D agonist to treat migraine. [1]

Sources

1. Drug label (DailyMed): Zolmitriptan orally disintegrating tablets — mechanism of action and pharmacology. https://dailymed.nlm.nih.gov/